| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.7M | +2.4% | +9.1% |
| Gross Profit | $14.0M | -1.0% | +8.6% |
| R&D Expense | $2.3M | +6.6% | +13.5% |
| SG&A Expense | $3.9M | -4.3% | +7.2% |
| Operating Income | -$7.6M | +16.8% | +19.3% |
| Pre-tax Income | -$8.6M | +13.0% | +17.1% |
| Income Tax | $85K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29.7M | -15.0% | +71.7% |
| Accounts Receivable | $11.3M | +0.3% | +0.5% |
| Inventory | $11.6M | +1.6% | -15.0% |
| Current Assets | $56.0M | -7.7% | +27.0% |
| Total Assets | $61.6M | -8.8% | +16.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.3M | — | — |
| Capital Expenditures | $357K | — | — |
| Investing Cash Flow | $654K | — | — |
| Financing Cash Flow | -$95K | — | — |
| Free Cash Flow | -$23.7M | — | — |
| +157.6% |
| — |
| Net Income | -$8.6M | +13.3% | +17.1% |
| EPS (Basic) | -$0.19 | +13.6% | +54.8% |
| EPS (Diluted) | -$0.19 | +13.6% | +54.8% |
| $17.0M |
| -10.9% |
| +0.7% |
| Long-term Debt | $41.5M | +0.3% | +1.3% |
| Total Liabilities | $60.0M | +2.9% | +1.3% |
| Stockholders' Equity | $1.6M | -83.0% | +124.8% |